BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26

• GlaxoSmithKline Launches New Standalone Unit to Research and Develop Medicines for Rare Diseases

  February 4, 2010

   · 

  3 min read
• Genetown

  Alkermes Unveils Long-Acting Injectable Proprietary Platform for Treatment of Schizophrenia and Other CNS Disorders

  February 4, 2010

   · 

  1 min read
• Launch of Ipsen’s Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer

  February 4, 2010

   · 

  1 min read
• Drug Development

  Protalix Biotherapeutics Announces Presentation of Phase III Taliglucerase Alfa Data at WORLD Lysosomal Disease Network

  February 4, 2010

   · 

  3 min read
• Genetown

  Inverness Medical Innovations, Inc. Second Study Supports that NGAL Test Identifies Acute Kidney Injury Early in Critically Ill Patients

  February 4, 2010

   · 

  3 min read
• St. Jude Medical Announces IRASE AF Clinical Trial To Evaluate Cardiac Ablation Catheter System For Treatment Of Atrial Fibrillation

  February 4, 2010

   · 

  1 min read
• FDA

  Polymedco: Advanced High Throughput Automated Immunoassay Fecal Occult Blood Test (FIT) System Receives FDA Clearance

  February 4, 2010

   · 

  2 min read
• Business

  Sistemic Closes $1 Million Series A Funding Round

  February 4, 2010

   · 

  2 min read
• FDA

  BTG plc Receives First European Regulatory Approval for DigiFab(TM)

  February 4, 2010

   · 

  1 min read
• Policy

  Lux Biosciences Files for LUVENIQ(TM) Approval in US and Europe for Noninfectious Uveitis

  February 4, 2010

   · 

  1 min read